CryoSave

What CryoSave does

CryoSave South Africa (Pty) Ltd is a private biotechnology company headquartered in Pretoria, South Africa, that specializes in stem cell banking, cord blood processing, and tissue engineering for both newborns and adults. Its core offering is the cryogenic collection, processing, and long-term storage of stem cells harvested from umbilical cord blood and tissue at birth, with a secondary service line for adult stem cells derived from fatty tissues through approved medical partners. The company operates a state-of-the-art laboratory with professionally trained staff and holds AABB international accreditation (since 2017), a SAHPRA license, and Department of Health authorization, positioning it as a fully regulated and accredited stem cell bank in the South African market.

The business operates on a subscription-based recurring revenue model, where families pay for the collection, processing, and multi-year storage of stem cells, with personalized payment plans offered to accommodate individual financial circumstances. Go-to-market is sales-led, targeting expectant parents through a direct-to-consumer website with quote-request CTAs, baby exhibits, customer testimonials, and educational content anchored by its Medical Director (Dr. Peter Koll). Channel partnerships with medical aid funds (Momentum Multiply, CAMAF) and industry associations (Cord Blood Association, Parents Guide Cord Blood) extend cryosave's reach into insurance and healthcare ecosystems.

Strategic positioning is premised on regulatory credibility, brand association (claiming part of a global network serving more than 5 million families) and flexible payment options. The company is described as being "Powered by Aluma Capital," though the exact nature of this relationship (parent, investor, or technology partner) is not disclosed. The firm operates exclusively in South Africa with no disclosed expansion into additional geographies, and there is no disclosed funding, M&A activity, or patent portfolio in the available data.

Name

CryoSave

Legal name

CryoSave South Africa (Pty) Ltd

Website

https://cryosave.co.za

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CryoSave South Africa is a Pretoria-based stem cell bank that collects, processes, and cryogenically stores umbilical cord blood and tissue from newborns and adult-derived stem cells from fatty tissues, serving expectant parents and families through a subscription-based, sales-led model with flexible payment plans.

Ownership category

akta.pro rank

Product category

Stem Cell Banking

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

• Stem cell banking
• Cord blood storage
• Umbilical cord tissue
• Adult stem cell storage
• Cryopreservation services

Headquarters

HQ city

Pretoria

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Stem Cell Banking Services: CryoSave generates revenue through stem cell banking services, charging families for the collection, processing, and long-term storage of stem cells. The company offers flexible payment plans personalized to customer financial needs.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

CryoSave collects, processes, and cryogenically stores stem cells for newborns (from umbilical cord blood and tissue) and for adults and older children (from fatty tissues via approved medical partners). The company sells long-term stem cell banking subscriptions to expectant parents, families, and adults, with flexible personalized payment plans.

Product overview

CryoSave is a stem cell banking company operating in South Africa, offering two primary services: Newborn Stem Cell Storage (preserving umbilical cord blood and tissue stem cells at birth) and Adult Stem Cell Storage (storing stem cells derived from fatty tissues). The company positions itself as SA's Premier Stem Cell Bank, serving newborns, adults, and families with flexible payment options.

Differentiator

Problem solved

Functional benefit

Products and services

• Newborn Stem Cell Storage Storage service that preserves a newborn's umbilical cord blood and tissue stem cells collected at birth, intended for potential future regenerative or therapeutic medical use. Targeted at expectant parents and families.
• Adult Stem Cell Storage Storage service for stem cells derived from fatty tissues of adults and older children, collected through CryoSave's approved medical partners, intended for potential future therapeutic or regenerative medical use.

Quantifiable outcome

• More than 5 million families worldwide trust CryoSave for stem cell banking

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Parents Guide Cord BloodminorGTM or Marketing PartnerPartner organization providing educational resources and marketing support for cord blood awareness and stem cell banking services.
• Cord Blood AssociationcoreStrategic or Co-development PartnerIndustry association partner for cord blood standards and best practices in stem cell banking.
• Momentum MultiplyminorGTM or Marketing PartnerHealth and wellness partner offering integrated services for members seeking stem cell banking.
• CAMAFminorGTM or Marketing PartnerMedical aid fund partner providing stem cell banking options for members.
• Angelic KeepsakesminorStrategic or Co-development PartnerPartner for keepsake and memory products complementing the birth and stem cell banking experience.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cells4Life: UK-based private cord blood and tissue bank with whole blood storage options. Closely comparable service model targeting expectant parents with multi-decade storage contracts.
• Cord Blood Registry (CBR): Largest private cord blood bank in the United States, offering newborn cord blood and cord tissue cryopreservation with similar subscription-based long-term storage model. Closest functional peer to CryoSave's core service offering.
• FamilyCord: US-based private cord blood bank offering cord blood and cord tissue cryopreservation. Direct competitor serving the same expectant parent segment with similar long-term storage subscription model.
• Smart Cells International: UK-based private stem cell bank offering cord blood and tissue storage. Direct peer with similar positioning as a niche private bank targeting the same expectant parent customer segment.
• Americord Registry: US-based private cord blood bank with direct-to-consumer sales model. Comparable newer-generation private stem cell bank targeting expectant parents with similar service bundles.
• ViaCord: Established US cord blood and tissue banking service (formerly part of PerkinElmer, now Revvity). Direct competitor offering newborn stem cell collection, processing, and long-term cryogenic storage with comparable value proposition.
• StemCyte: Hybrid public/private cord blood bank operating internationally including Asia and the Middle East. Comparable umbilical cord blood and tissue banking services with established regulatory credentials.
• Cryo-Cell International: US-based public company offering private cord blood and menstrual stem cell banking services. Direct competitor in the consumer-facing stem cell banking space with similar recurring revenue model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/CryoSaveSA
• LinkedInlinkedin.com/company/cryosave-pty-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CryoSave